REQUEST A DEMO
Total
USD $0.00
Search more companies

Stratec Biomedical SRL (Romania)

Main Activities: Computer Systems Design and Related Services
Full name: Stratec Biomedical SRL Profile Updated: August 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Stratec Biomedical SRL is based in Romania, with the head office in CLUJ-NAPOCA. It operates in the Computer Systems Design and Related Services sector. It was incorporated on December 20, 2007. There are currently 150 (2022) people employed by Stratec Biomedical SRL. From the latest financial highlights, Stratec Biomedical SRL reported a net sales revenue increase of 37.87% in 2023. There was a total growth of 4.82% in Stratec Biomedical SRL’s total assets over the same period. The enterprise’s net profit margin increased by 2.18% in 2023.

Headquarters
Strada Traian Nr. 34
CLUJ-NAPOCA; Cluj; Postal Code: 400046

Contact Details: Purchase the Stratec Biomedical SRL report to view the information.

Basic Information
Total Employees:
Purchase the Stratec Biomedical SRL report to view the information.
Outstanding Shares:
Purchase the Stratec Biomedical SRL report to view the information.
Registered Capital:
Purchase the Stratec Biomedical SRL report to view the information.
Incorporation Date:
December 20, 2007
Key Executives
Purchase this report to view the information.
Administrator
Purchase this report to view the information.
Administrator
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Stratec Biomedical SRL report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Net sales revenue
37.87%
Total operating revenue
37.64%
Operating profit (EBIT)
96.2%
EBITDA
123.27%
Net Profit (Loss) for the Period
105.08%
Total assets
4.82%
Total equity
14.2%
Operating Profit Margin (ROS)
2.46%
Net Profit Margin
2.18%
Return on Equity (ROE)
5.51%
Quick Ratio
-1.03%
Cash Ratio
2.25%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?